<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-61959</identifier>
<setSpec>0034-947X</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Essential thrombocytosis inthe pediatric age</dc:title>
<dc:description xml:lang="en">Thrombocytosis is a common finding in childhood, especially in relationship with infections. However, primary or essential thrombocytosis is an uncommon disorder in the pediatric age. It consists in a chronic myeloproliferative condition that primarily affects the megakaryocytic line. Its main clinical manifestations include headache, bleeding and thrombotic phenomena, although there are also asymptomatic cases, especially in childhood. The treatment and management of this disease in children continue to be a controversial subject. We present the case of a boy who was 3 months old on diagnosis, with persistent thrombocytosis and no clinical manifestation who was diagnosed of essential thrombocytosis. He was prescribed antiaggregant therapy with no subsequent complications (AU)</dc:description>
<dc:creator>Muñoz Villa, A</dc:creator>
<dc:creator>Maldonado Regalado, M. S</dc:creator>
<dc:creator>Buenache Espartosa, R</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">La trombocitosis es un hallazgo frecuente en la infancia, especialmente en relación coinfecciones. Sin embargo, la trombocitosis primaria o trombocitosis esencial es un trastorno infrecuente en la edad pediátrica; consiste en un proceso mieloproliferativo crónico que afecta de forma primaria a la línea megacariocítica. Sus principales manifestaciones clínicas incluyen cefalea, fenómenos hemorrágicos y trombóticos; aunque también existen casos asintomáticos, especialmente en la infancia. El tratamiento y manejo de esta enfermedad en niños continúa siendo actualmente un tema controvertido. Presentamos el caso de un niño de 3 meses de edad, con trombocitosis persistente, sin manifestaciones clínicas, que fue diagnosticado de trombocitosis esencial, pautándose tratamiento antiagregante sin complicaciones posteriores (AU)</dc:description>
<dc:source>Rev Esp Pediatr;63(5): 410-412, sept.-oct. 2007. tab</dc:source>
<dc:identifier>ibc-61959</dc:identifier>
<dc:title xml:lang="es">Trombocitosis esencial en la edad pediátrica</dc:title>
<dc:subject>^d7399</dc:subject>
<dc:subject>^d14307^s22032</dc:subject>
<dc:subject>^d14307^s22012</dc:subject>
<dc:subject>^d22965^s22073</dc:subject>
<dc:subject>^d21012</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d24408^s22016</dc:subject>
<dc:subject>^d6412^s22032</dc:subject>
<dc:subject>^d14307^s22080</dc:subject>
<dc:subject>^d6412^s22012</dc:subject>
<dc:subject>^d22965^s22000</dc:subject>
<dc:subject>^d24408^s22012</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d6412^s22080</dc:subject>
<dc:type>article</dc:type>
<dc:date>200710</dc:date>
</metadata>
</record>
</ibecs-document>
